Refine by
Patient Testing Articles & Analysis
27 articles found
The new joint guideline states that if the FeNO result is raised above 50 ppb, and supports the clinical history and examination of the patient, no further testing is required – this is adequate to diagnose asthma. ...
Moreover, they provide a safer and more ethical alternative to animal testing by enabling in vitro experimentation. One notable application of stable cell lines is in cancer research, where they are used to model tumor behavior and test potential treatments. ...
If you’ve ever studied the causes of a skin complaint or damaged hair, chances are someone on the internet has pointed the finger at SLS, or sodium lauryl (or laureth) sulfate, a common ingredient in beauty products, washes, toothpastes and even cleaning products.So what does this ingredient do, why is it in everything, and what does the evidence say about how safe it ...
The NObreath® offers two test modes: A 12-second test mode and a 10-second test mode for those up to 10 years old who cannot complete the 12-second test mode. ...
Patients receive instant results, eliminating wait times. Intended for adult and paediatric patients**, the NObreath® offers two test modes: a 10-second test mode for those up to 10 years old who cannot complete the 12-second test mode. ...
Patients with other rheumatologic diseases were generally negative for ACA with a few exceptions, such as those with RA overlap syndromes. ACA values correlated with titers of rheumatoid factor. The ACA test segregated seronegative RA patients into two distinct categories, while seropositive RA patients with a positive ACA had ...
This could revolutionize the field of organ transplantation and offer hope to patients with organ failure. Drug testing: Bioprinted tissues can be used to test new drugs and therapies in a more realistic and humane way than traditional animal models. ...
ByMatexcel
The ability to influence the differentiation of iPSCs, combined with the fact they can be generated from patients’ own cells, has opened intriguing possibilities for patient-specific drug testing, disease modeling, and therapeutic transplantation. ...
An important aspect to producing new innovative solutions to medical testing is that the tests have to be easily tolerated by the patient. ...
The ClarityDX Prostate® test provides patients and physicians with an accurate prediction of clinically significant prostate cancer to support decision-making and improve health outcomes for men suspected of having prostate cancer. ...
Primary care practitioners are often the first to address a patient’s or family’s concerns about memory loss or the possibility of dementia. Detecting cognitive decline as early as possible is fundamental to a patient’s ability to receive earlier access to treatments and therapies, and, consequently, more effective treatment and improved health ...
Sleep apnea is typically treated with a continuous positive airway pressure device, which pushes air down a patient’s throat to prevent obstruction and to allow the patient to breathe normally during sleep. ...
However, at the time, I wasn’t testing every patient age 50 and older. I was giving patients the option and asking them if they wanted to be tested. ...
Innovations and Iterations In the consumer tech world, iterations happen very fast, though most inventions are not ‘one and done’ masterpieces: the Dyson cyclone vacuum cleaner made 5,127 prototypes. In the medical device world, development takes longer because of the appropriate and necessary regulations and need for safety. Using an agile approach, but with safety and reliability ...
One of the biggest challenges is making sure travelers can be tested and receive test results quickly enough, since the longer someone has to wait for test results, the longer they have to isolate themselves to avoid becoming infected between testing and departure. ...
ByIGeneX
The need for providing dialysis to patients in the ICU has increased overtime. Delivery of this care is challenging to health care systems (HCS) both in costs and ...
Changes in smell is a prominent symptom of COVID-19, as has consistently been demonstrated in many countries. By using the odor tester on patients, we could quickly detect COVID-19 presence, even at low infection rates. ...
TAILOR-PCI was a 7-year 5,300-patient clinical trial of precision medicine for cardiac stent patients, funded by Mayo Clinic and the National Institutes of Health (NIH). ...
It’s not just about surgery. More and more medical testing and diagnosis is done using the patient’s breath. Testing a patient’s breath to monitor a variety of issues, including asthma, gastrointestinal issues and cancer, is often less invasive and less expensive than other types of tests. ...
After seven years and 5,300-patients tested, the results of the landmark TAILOR-PCI trial were announced in a virtual ACC session. This trial investigated whether a prospective approach using rapid on-site CYP2C19 testing could improve patient outcomes when selecting P2Y12 inhibitor therapy following PCI procedure. ...